AstraZeneca invests $300 million to establish new cell therapy manufacturing facility in Maryland

AstraZeneca facility in Maryland

Maryland Governor Wes Moore announced that AstraZeneca would invest $300 million to construct a new manufacturing facility in Rockville, a city with roughly 70,000 inhabitants that is about 17 miles from Washington, D.C. The facility will focus on cell therapies for cancer treatment. The 84,000 square-foot facility, slated for completion in 2026, will enable global clinical trials and commercial supply of AstraZeneca’s CAR-T cancer therapies. AstraZeneca estimates the plant to create 150 new high-skilled jobs.

Incentives played a role in new plant

To support AstraZeneca’s new manufacturing facility in Rockville, Maryland, the state and county are providing financial incentives, including a $500,000 conditional loan from the Maryland Department of Commerce’s Advantage Maryland program and a $100,000 conditional grant from Montgomery County’s Economic Developm…

Read more
  • 0